Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D7S9LP
|
|||
| Drug Name |
Somapacitan
|
|||
| Synonyms |
1338578-34-9; Somapacitan [INN]; Somapacitan [WHO-DD]; Somapacitan [USAN:INN]; UNII-8FOJ430U94; 8FOJ430U94; EX-A4353; UNII-F1 component VTUYEWRWJTWXPQ-IWWWZYECSA-N; Q27270325
Click to Show/Hide
|
|||
| Drug Type |
Peptide
|
|||
| Indication | Growth hormone deficiency [ICD-11: 5A61.3] | Approved | [1] | |
| Company |
Novo Nordisk
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C54H95N13O20S2
|
|||
| Canonical SMILES |
C(CCCCCCCC1=NNN=N1)CCCCCCCC(=O)NS(=O)(=O)CCCC(=O)NCCOCCOCC(=O)NC(CCC(=O)NC(CCC(=O)NCCOCCOCC(=O)NC(CCCCNC(=O)CSCC(C(=O)O)N)C(=O)N)C(=O)O)C(=O)O
|
|||
| InChI |
1S/C54H95N13O20S2/c55-39(52(76)77)37-88-38-50(74)57-25-15-14-17-40(51(56)75)60-48(72)35-86-32-30-85-29-27-59-45(69)23-21-41(53(78)79)61-46(70)24-22-42(54(80)81)62-49(73)36-87-33-31-84-28-26-58-44(68)20-16-34-89(82,83)65-47(71)19-13-11-9-7-5-3-1-2-4-6-8-10-12-18-43-63-66-67-64-43/h39-42H,1-38,55H2,(H2,56,75)(H,57,74)(H,58,68)(H,59,69)(H,60,72)(H,61,70)(H,62,73)(H,65,71)(H,76,77)(H,78,79)(H,80,81)(H,63,64,66,67)/t39-,40-,41-,42-/m0/s1
|
|||
| InChIKey |
VTUYEWRWJTWXPQ-IWWWZYECSA-N
|
|||
| CAS Number |
CAS 1338578-34-9
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.